Hypera Stock

Hypera Long-term Debt

The Long-Term Debt of Hypera (HYPE3.SA) as of Aug 19, 2026 is 8.01 B BRL. In the previous year, Long-Term Debt was 7.99 B BRL — a change of 0.24% (higher).

Long-term Debt

8.01 BBRL

YoY

0.24%

Last updated:

Long-Term Debt of Hypera is 2026 8.01 B BRL. Long-Term Debt of Hypera was 2025 7.99 B BRL. It decreases by 0.24% higher compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Long-Term Debt of Hypera is 8.01 B BRL in 2026.

Long-Term Debt of Hypera changed from 7.99 B BRL to 8.01 B BRL, representing a 0.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Hypera since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Hypera historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Hypera

All Key Metrics — Hypera